Tumor Angiogenesis: Initiation and Targeting - Therapeutic Targeting of an FGF-Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas -
Elena Tassi, Anton Wellstein
Cancer Res Treat. 2006;38(4):189-197.   Published online 2006 Dec 31     DOI: https://doi.org/10.4143/crt.2006.38.4.189
Citations to this article as recorded by Crossref logo
The potential role of tubeimosides in cancer prevention and treatment
Md Sodrul Islam, Chenying Wang, Jingyou Zheng, Narayan Paudyal, Yongliang Zhu, Hongxiang Sun
European Journal of Medicinal Chemistry.2019; 162: 109.     CrossRef
Immune Cell Types and Secreted Factors Contributing to Inflammation-to-Cancer Transition and Immune Therapy Response
Xingwei Chen, Chi Xu, Shengjun Hong, Xian Xia, Yaqiang Cao, Joseph McDermott, Yonglin Mu, Jing-Dong J. Han
Cell Reports.2019; 26(7): 1965.     CrossRef
Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response
Qingyu Xu, Junfei Gu, You Lv, Jiarui Yuan, Nan Yang, Juan Chen, Chunfei Wang, Xuefeng Hou, Xiaobin Jia, Liang Feng, Guowen Yin
Oncology Letters.2018;[Epub]     CrossRef
The role of the signaling pathway FGF/FGFR in pancreatic cancer
D. A. Gnatenko, E. P. Kopantsev, E. D. Sverdlov
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.2017; 11(2): 101.     CrossRef
Role of fibroblast growth factors in pancreatic cancer
D.A. Gnatenko, E.P. Kopantsev, E.D. Sverdlov
Biomeditsinskaya Khimiya.2016; 62(6): 622.     CrossRef
The anticancer effect of Huaier (Review)
XIAOJIN SONG, YAMING LI, HANWEN ZHANG, QIFENG YANG
Oncology Reports.2015; 34(1): 12.     CrossRef
The “angiogenetic ladder”, step-wise angiogenesis inhibition in metastatic colorectal cancer
Riccardo Giampieri, Mario Scartozzi, Michela Del Prete, Agnese Fulli, Luca Faloppi, Maristella Bianconi, Elena Maccaroni, Stefano Cascinu
Cancer Treatment Reviews.2014; 40(8): 934.     CrossRef
Desmoplasia in Pancreatic Cancer. Can We Fight It?
E. E. Merika, K. N. Syrigos, M. W. Saif
Gastroenterology Research and Practice.2012; 2012: 1.     CrossRef
Anti-angiogenic and antitumor activities of Huaier aqueous extract
XIAOLONG WANG, NING ZHANG, QIANG HUO, QIFENG YANG
Oncology Reports.2012; 28(4): 1167.     CrossRef
Identification of the Oxidative and Conjugative Enzymes Involved in the Biotransformation of Brivanib
Jiachang Gong, Jinping Gan, Ramaswamy A. Iyer
Drug Metabolism and Disposition.2012; 40(1): 219.     CrossRef
Metabolic Chiral Inversion of Brivanib and Its Relevance to Safety and Pharmacology
Jiachang Gong, Jinping Gan, Eric Masson, Shariq Syed, Yuan-Qing Xia, Daphne Williams, Janice Pursley, Mohammed Jemal, W. Griff Humphreys, Ramaswamy A. Iyer
Drug Metabolism and Disposition.2012; 40(12): 2374.     CrossRef
Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran, Ramaswamy A. Iyer
Drug Metabolism and Disposition.2011; 39(5): 891.     CrossRef
Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2
Ho-Kyun Oh, Jung-Min Ha, Eunju O, Byung Hun Lee, Suk Keun Lee, Byoung-Shik Shim, Yong-Kil Hong, Young Ae Joe
Cancer Research.2007; 67(10): 4851.     CrossRef